4131 - 4140 of 8808 Results
Title
Year
-
OPENTitle: SOD1-Related Cerebellar Ataxia and Motor Neuron Disease: Cp Variant as Functional Modifier?Journal Name: The CerebellumPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12311-023-01527-3Citation Count: 3
-
OPENTitle: Associations of Apolipoprotein ε4 Genotypes with Motor and Nonmotor Symptoms in Parkinson's Disease: A Cross‐Sectional StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 11Start Page: 1611End Page: 1619Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13862Best OA location URL: https://doi.org/10.1002/mdc3.13862Citation Count: 1
-
OPENTitle: Differential transcript usage unravels transcriptional alterations in Alzheimer's disease human brainsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.038695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.038695Citation Count: 0
-
OPENTitle: Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson DiseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 2Start Page: 320End Page: 331Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25788Best OA location URL: https://pub.dzne.de/record/153306Citation Count: 94
-
OPENTitle: Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 1Start Page: 113End Page: 122Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29251Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9851979Citation Count: 13
- Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)2021OPENTitle: Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 96Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.96.15_supplement.4286Citation Count: 3
-
OPENTitle: Gut mucosal cells transfer α-synuclein to the vagus nerveJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 8Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.172192Best OA location URL: https://doi.org/10.1172/jci.insight.172192Citation Count: 22
- Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation2023OPENTitle: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregationJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 46Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adi8716Best OA location URL: https://doi.org/10.1126/sciadv.adi8716Citation Count: 106
- Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B2023OPENTitle: Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55BJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 50Start Page: eadj1205End Page: eadj1205Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adj1205Best OA location URL: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/Lipofectamine_RNAiMAX_Reag_protocol.pdfCitation Count: 25
-
OPENTitle: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structuresJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 9Issue #: 48Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adk6191Best OA location URL: https://doi.org/10.1126/sciadv.adk6191Citation Count: 27